-
Abstract: Summary The role of neuroimmunomodulation in allergic diseases is a research hotspot in recent years. Allergic rhinitis(AR) is caused by overactive immune response to a foreign antigen in nasal mucosa. Immune cells release inflammatory mediators(including histamine, cytokines and neurotrophins), which directly activate peripheral neurons to mediate nasal congestion, itching, sneezing, and other hyperresponsive symptoms. Upon activation, these peripheral neurons release neurotransmitters (including acetylcholine and norepinephrine) and neuropeptides(including calcitonin gene-related peptide, substance P and vasoactive intestinal peptide) that directly act on immune cells to drive allergic inflammation. Neuro-immune signaling may play a significant role in the pathophysiology of AR. Therefore, a better understanding of these cellular and molecular neuro-immune interactions may inspire the discovery of new targets and novel therapies.
-
Key words:
- rhinitis, allergic /
- neuroimmunomodulation /
- neuropeptides /
- nasal hyperresponsiveness
-
-
[1] Wang XD, Zheng M, Lou HF, et al. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011[J]. Allergy, 2016, 71(8): 1170-1180. doi: 10.1111/all.12874
[2] 张竞莹, 李璐鑫, 冀永进, 等. 单侧翼管神经切断术治疗变应性鼻炎的疗效及影响因素分析[J]. 中国耳鼻咽喉颅底外科杂志, 2020, 26(6): 666-669. https://www.cnki.com.cn/Article/CJFDTOTAL-ZEBY202006013.htm
[3] Le DD, Schmit D, Heck S, et al. Increase of Mast Cell-Nerve Association and Neuropeptide Receptor Expression on Mast Cells in Perennial Allergic Rhinitis[J]. Neuroimmunomodulation, 2016, 23(5/6): 261-270.
[4] Durcan N, Costello RW, McLean WG, et al. Eosinophil-mediated cholinergic nerve remodeling[J]. Am J Respir Cell Mol Biol, 2006, 34(6): 775-786. doi: 10.1165/rcmb.2005-0196OC
[5] Breiteneder H, Diamant Z, Eiwegger T, et al. Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care[J]. Allergy, 2019, 74(12): 2293-2311. doi: 10.1111/all.13851
[6] Voisin T, Bouvier A, Chiu IM. Neuro-immune interactions in allergic diseases: novel targets for therapeutics[J]. Int Immunol, 2017, 29(6): 247-261. doi: 10.1093/intimm/dxx040
[7] Galli SJ, Gaudenzio N, Tsai M. Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns[J]. Annu Rev Immunol, 2020, 38: 49-77. doi: 10.1146/annurev-immunol-071719-094903
[8] Mollanazar NK, Smith PK, Yosipovitch G. Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?[J]. Clin Rev Allergy Immunol, 2016, 51(3): 263-292. doi: 10.1007/s12016-015-8488-5
[9] 李秋婷, 赵长青. 肥大细胞脱颗粒的神经免疫调控机制研究[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(12): 1118-1120. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201512019.htm
[10] Hu H, Zhang R, Fang X, et al. Effects of endogenous substance P expression on degranulation in RBL-2H3 cells[J]. Inflamm Res, 2011, 60(6): 541-546. doi: 10.1007/s00011-010-0301-6
[11] Larsson O, Tengroth L, Xu Y, et al. Substance P represents a novel first-line defense mechanism in the nose[J]. J Allergy Clin Immunol, 2018, 141(1): 128-136. e3. doi: 10.1016/j.jaci.2017.01.021
[12] Saunders CJ, Christensen M, Finger TE, et al. Cholinergic neurotransmission links solitary chemosensory cells to nasal inflammation[J]. Proc Natl Acad Sci U S A, 2014, 111(16): 6075-6080. doi: 10.1073/pnas.1402251111
[13] Wang H, Zhang R, Wu J, et al. Knockdown of neurokinin-1 receptor expression by small interfering RNA prevents the development of allergic rhinitis in rats[J]. Inflamm Res, 2013, 62(10): 903-910. doi: 10.1007/s00011-013-0649-5
[14] Subramanian H, Gupta K, Ali H. Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases[J]. J Allergy Clin Immunol, 2016, 138(3): 700-710. doi: 10.1016/j.jaci.2016.04.051
[15] Fujisawa D, Kashiwakura J, Kita H, et al. Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria[J]. J Allergy Clin Immunol, 2014, 134(3): 622-633. e9. doi: 10.1016/j.jaci.2014.05.004
[16] Sobkowiak P, Langwiński W, Nowakowska J, et al. Neuroinflammatory Gene Expression Pattern Is Similar between Allergic Rhinitis and Atopic Dermatitis but Distinct from Atopic Asthma[J]. Biomed Res Int, 2020, 2020: 7196981.
[17] Matsumoto Y, Yokoi H, Kimura T, et al. Gastrin-Releasing Peptide Is Involved in the Establishment of Allergic Rhinitis in Mice[J]. Laryngoscope, 2018, 128(11): E377-E384. doi: 10.1002/lary.27394
[18] Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders[J]. Gut, 2016, 65(1): 155-168. doi: 10.1136/gutjnl-2015-309151
[19] Ricciardolo F, Folkerts G, Folino A, et al. Bradykinin in asthma: Modulation of airway inflammation and remodelling[J]. Eur J Pharmacol, 2018, 827: 181-188. doi: 10.1016/j.ejphar.2018.03.017
[20] Nagira Y, Goto K, Tanaka H, et al. Prostaglandin D2 Modulates Neuronal Excitation of the Trigeminal Ganglion to Augment Allergic Rhinitis in Guinea Pigs[J]. J Pharmacol Exp Ther, 2016, 357(2): 273-280. doi: 10.1124/jpet.115.231225
[21] Liang WJ, Zhang G, Luo HS, et al. Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome[J]. Gut Liver, 2016, 10(3): 382-390.
[22] Skaper SD. Nerve growth factor: a neuroimmune crosstalk mediator for all seasons[J]. Immunology, 2017, 151(1): 1-15. doi: 10.1111/imm.12717
[23] Chowdary PD, Che DL, Cui B. Neurotrophin signaling via long-distance axonal transport[J]. Annu Rev Phys Chem, 2012, 63: 571-594. doi: 10.1146/annurev-physchem-032511-143704
[24] Raap U, Fokkens W, Bruder M, et al. Modulation of neurotrophin and neurotrophin receptor expression in nasal mucosa after nasal allergen provocation in allergic rhinitis[J]. Allergy, 2008, 63(4): 468-475. doi: 10.1111/j.1398-9995.2008.01626.x
[25] 王豪, 陈仁辉, 钟燕青, 等. 变应性鼻炎患者外周血中神经营养因子mRNA的表达及与Th1/Th2免疫失衡的关系[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(14): 1024-1027. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201414004.htm
[26] Gelincik A, Aydın F, Ozerman B, et al. Enhanced nerve growth factor expression by mast cells does not differ significantly between idiopathic and allergic rhinitis[J]. Ann Allergy Asthma Immunol, 2012, 108(6): 396-401. doi: 10.1016/j.anai.2012.04.006
[27] Han H, Yang C, Zhang Y, et al. Vascular Endothelial Growth Factor Mediates the Sprouted Axonogenesis of Breast Cancer in Rat[J]. Am J Pathol, 2021, 191(3): 515-526. doi: 10.1016/j.ajpath.2020.12.006
[28] Masuoka T, Yamashita Y, Yoshida J, et al. Sensitization of glutamate receptor-mediated pain behaviour via nerve growth factor-dependent phosphorylation of transient receptor potential V1 under inflammatory conditions[J]. Br J Pharmacol, 2020, 177(18): 4223-4241. doi: 10.1111/bph.15176
[29] Minnone G, De Benedetti F, Bracci-Laudiero L. NGF and Its Receptors in the Regulation of Inflammatory Response[J]. Int J Mol Sci, 2017, 18(5): 1028. doi: 10.3390/ijms18051028
[30] Liu BW, Zhang J, Hong YS, et al. NGF-Induced Nav1.7 Upregulation Contributes to Chronic Post-surgical Pain by Activating SGK1-Dependent Nedd4-2 Phosphorylation[J]. Mol Neurobiol, 2021, 58(3): 964-982. doi: 10.1007/s12035-020-02156-1
[31] Metcalfe DD, Pawankar R, Ackerman SJ, et al. Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases[J]. World Allergy Organ J, 2016, 9: 7. doi: 10.1186/s40413-016-0094-3
[32] Herraiz C, Journé F, Abdel-Malek Z, et al. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT[J]. Mol Endocrinol, 2011, 25(1): 138-156. doi: 10.1210/me.2010-0217
[33] Wang W, Guo DY, Lin YJ, et al. Melanocortin Regulation of Inflammation[J]. Front Endocrinol(Lausanne), 2019, 10: 683. doi: 10.3389/fendo.2019.00683
[34] Böhm M, Apel M, Sugawara K, et al. Modulation of basophil activity: a novel function of the neuropeptide α-melanocyte-stimulating hormone[J]. J Allergy Clin Immunol, 2012, 129(4): 1085-1093. doi: 10.1016/j.jaci.2011.11.012
[35] Kleiner S, Braunstahl GJ, Rüdrich U, et al. Regulation of melanocortin 1 receptor in allergic rhinitis in vitro and in vivo[J]. Clin Exp Allergy, 2016, 46(8): 1066-1074. doi: 10.1111/cea.12759
[36] El-Shazly AE, Roncarati P, Lejeune M, et al. Tyrosine kinase inhibition is an important factor for gene expression of CRTH2 in human eosinophils and lymphocytes: A novel mechanism for explaining eosinophils recruitment by the neuro-immune axis in allergic rhinitis[J]. Int Immunopharmacol, 2017, 45: 180-186. doi: 10.1016/j.intimp.2017.02.015
[37] El-Shazly AE, Begon DY, Kustermans G, et al. Novel association between vasoactive intestinal peptide and CRTH2 receptor in recruiting eosinophils: a possible biochemical mechanism for allergic eosinophilic inflammation of the airways[J]. J Biol Chem, 2013, 288(2): 1374-1384. doi: 10.1074/jbc.M112.422675
[38] Kim DH, Park IH, Cho JS, et al. Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis[J]. Am J Rhinol Allergy, 2011, 25(1): e44-47. doi: 10.2500/ajra.2011.25.3568
[39] Drake MG, Scott GD, Blum ED, et al. Eosinophils increase airway sensory nerve density in mice and in human asthma[J]. Sci Transl Med, 2018, 10(457): eaar 8477. doi: 10.1126/scitranslmed.aar8477
[40] Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects[J]. Int Immunopharmacol, 2011, 11(11): 1646-1662. doi: 10.1016/j.intimp.2011.07.005
[41] Akasheh N, Walsh MT, Costello RW. Eosinophil peroxidase induces expression of cholinergic genes via cell surface neural interactions[J]. Mol Immunol, 2014, 62(1): 37-45. doi: 10.1016/j.molimm.2014.05.014
[42] Jacoby DB, Gleich GJ, Fryer AD. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor[J]. J Clin Invest, 1993, 91(4): 1314-1318. doi: 10.1172/JCI116331
[43] Liu Z, Yang X, Liu X, et al. Analysis of expression of ILC2 cells in nasal mucosa based on animal model of allergic bacterial infection rhinitis[J]. J Infect Public Health, 2021, 14(1): 77-83. doi: 10.1016/j.jiph.2019.09.010
[44] Kato A. Group 2 Innate Lymphoid Cells in Airway Diseases[J]. Chest, 2019, 156(1): 141-149. doi: 10.1016/j.chest.2019.04.101
[45] Wallrapp A, Riesenfeld SJ, Burkett PR, et al. Erratum: The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation[J]. Nature, 2017, 551(7682): 658.
[46] Cardoso V, Chesné J, Ribeiro H, et al. Neuronal regulation of type 2 innate lymphoid cells via neuromedin U[J]. Nature, 2017, 549(7671): 277-281. doi: 10.1038/nature23469
[47] Sui P, Wiesner DL, Xu J, et al. Pulmonary neuroendocrine cells amplify allergic asthma responses[J]. Science, 2018, 360(6393): eaan 8546. doi: 10.1126/science.aan8546
[48] Nussbaum JC, Van Dyken SJ, von Moltke J, et al. Type 2 innate lymphoid cells control eosinophil homeostasis[J]. Nature, 2013, 502(7470): 245-248. doi: 10.1038/nature12526
[49] Moriyama S, Brestoff JR, Flamar AL, et al. β2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses[J]. Science, 2018, 359(6379): 1056-1061. doi: 10.1126/science.aan4829
-
下载:
图(1)
计量
- 文章访问数: 1549
- PDF下载数: 688
- 施引文献: 0